Dysport

About Galderma Group

Galderma Group is a premier dermatology-focused pharmaceutical company headquartered in Switzerland, serving healthcare professionals and patients worldwide with medical dermatology treatments, aesthetic solutions, and consumer skincare products. The company has established itself as a leader in dermatological innovation through its extensive research and development programs and comprehensive product portfolio. Following its successful IPO in 2024, Galderma continues to expand its global presence and advance its pipeline of dermatology treatments.

About Ipsen

Ipsen is a well-established French biopharmaceutical company that has evolved from its 1986 founding to become a global leader in specialty care medicines. The company focuses on areas of high unmet medical need across oncology, rare diseases, and neuroscience, with particular expertise in neuroendocrine tumors, rare liver conditions like PBC, and neurological disorders including spasticity. Ipsen's strategy emphasizes targeted innovation and strategic partnerships to accelerate drug development and expand their pipeline. The company has demonstrated strong financial performance with consistent growth and maintains a robust balance sheet to support continued R&D investments and pipeline expansion.

Therapeutic Areas